Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 87, Issue 5, 1997, Pages 746-751

  Pluta, Ryszard M ^a   Oldfield, Edward H ^a   Boock, Robert J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cerebral blood flow; Cerebral vasospasm; Macaca cynomolgus; Nitric oxide; Nitric oxide donor; Subarachnoid hemorrhage

Indexed keywords

DIETHYLAMINE NITRIC OXIDE; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUCANTIME NITRIC OXIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROLI NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; VASOSPASM;

EID: 0030668002     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.5.0746     Document Type: Article

References (31)

1. Afshar J, Pluta R, Boock R, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118-122, 1995
2. Ayata C, Ma J, Meng W, et al: L-NA-sensitive rCBF augmentation during vibrissal stimulation in type III nitric oxide synthase mutant mice. J Cereb Blood Flow Metab 16:529-541, 1996
3. Carter L, Graham T, Zabramski J, et al: Postoperative monitoring of cerebral blood flow in patients harboring intracranial aneurysms. Neurol Res 12:214-218, 1990
4. Dedrick RL, Oldfield EH, Collins JM: Arterial drug infusion with extracorporeal removal. I. Theoretical basis with particular reference to the brain. Cancer Treat Rep 68:373-380, 1984
5. Dorsch N: Cerebral arterial spasm - a clinical review. Br J Neurosurg 9:403-412, 1995
6. Espinosa F, Weir B, Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part I: Clinical and radiological findings. J Neurosurg 60:1167-1175, 1984
7. Frazee JG, Giannotta SL, Stern ES: Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg 55:865-868, 1981
8. Heros R, Zervas N, Lavyne M, et al: Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy. Surg Neurol 6:227-229, 1976
9. Iadecola C, Pelligrino D, Moskowitz M, et al: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175-192, 1994
10. Ignarro LJ: Endothelial-derived NO: actions and properties. FASEB J 32:31-36, 1989
11. Kassell N, Peerless S, Durward Q, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced hypertension. Neurosurgery 11:337-343, 1982
12. Kassell N, Sasaki T, Colohan A, et al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562-572, 1985
13. Kassell NF, Torner JC: The International Cooperative Study in Timing of Aneurysm Surgery - an update. Stroke 15:566-570, 1984
14. Katsuki S: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin, and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucl Res 3:23-35, 1977
15. Keefer L, Nims R, Davies K, et al: "NONates" (1-substituted diazen-1-iuni-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268:281-294, 1996
16. Keilin D, Hartree E: Reaction of nitric oxide with haemoglobin and methemoglobin. Nature 139:548, 1937
17. Kistler J, Lees R, Candia G, et al: Intravenous nitroglycerin in experimental vasospasm. A preliminary report. Stroke 10: 26-29, 1979
18. Macdonald R, Weir B: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991
19. Maragos CM, Morley D, Wink DA: Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34: 3242-3247, 1991
20. Nelson RJ, Perry S, Hames TK, et al: Transcranial Doppler ultrasound studies of cerebral autoregulation and subarachnoid hemorrhage in the rabbit. J Neurosurg 73:601-610, 1990
21. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biologic activity of endothelium derived relaxing factor. Nature 327:524-526, 1987
22. Pluta R, Thompson B, Dawson T, et al: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648-654, 1996
23. Saavedra J, Southan G, Davies K, et al: Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem 39:4361-4365, 1996
24. Thompson BG, Pluta RM, Girton M, et al: Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg 84:71-78, 1995
25. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:27-36, 1990
26. Voldby B, Enevoldsen EM, Jensen FT: Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 62:59-67, 1985
27. Weir B, Grace M, Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173-181, 1978
28. Wennmalm A, Benthin G, Peterson AS: Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106:507-508, 1992
29. Wilkins R: Attempts at prevention or treatment of intracranial arterial spasm: an update. Neurosurgery 18:808-825, 1986
30. Zhang F, Iadecola C: Nitroprusside improves blood flow and reduces brain damage after focal ischemia. NeuroReport 4: 559-562, 1993
31. Zweifach B, Lipowsky H: Pressure-flow relations in blood and lymph microcirculation, in Renkin EM, Michel CC (eds): Microcirculation. Handbook of Physiology, Section 2, Vol 4, Part 1. Bethesda, MD: American Physiological Society, 1984, pp 251-307